Document Detail


Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
MedLine Citation:
PMID:  10150185     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Trimetazidine has been shown to improve anginal symptoms and exercise tolerance in patients with coronary artery disease (CAD). To determine the hemodynamic effects of trimetazidine, systemic hemodynamics were studied in 15 patients suffering from CAD (12 male, 3 female, mean age +/- SEM = 58.6 +/- 1.8 years). Cardiac index was determined by thermodilution method. Left ventricular and aortic pressures were measured using micromanometers (Miller Instruments). After basal measurements, patients were randomly given either placebo (n = 5) or one of two therapeutic doses of trimetazidine 1 mg.kg-1 (n = 5) or trimetazidine 1.5 mg.kg-1 (n = 5) in a double-blind procedure. Data were recorded 5, 10 and 20 min after intravenous drug bolus. Throughout the procedure, the evolution of systemic hemodynamic parameters was not statistically different between the three groups, in particular heart rate, cardiac index, systolic, diastolic and mean aortic pressures, end-diastolic ventricular pressure, mean capillary wedge pressure, pulmonary artery pressures or systemic vascular resistances. We conclude that, unlike other antianginal drugs (particularly beta-blockers, nitrates and calcium-channel inhibitors), trimetazidine does not modify systemic hemodynamics in patients with CAD. These results are consistent with a direct effect of trimetazidine on the ischemic myocardial cell previously reported.
Authors:
M Pornin; C Harpey; J Allal; P Sellier; P Ourbak
Related Documents :
21444835 - Clinical features of 8295 patients with resistant hypertension classified on the basis ...
2097065 - Intracoronary endothelin-1 increases coronary retrograde pressure by constricting arter...
6829785 - Ventricular filling pressure as a determinant of coronary blood flow during ischemia.
8498655 - Early administration of amrinone does not impair regional metabolism of o2 or lactate a...
8124065 - The effect of indomethacin on the circulatory and plasma noradrenaline responses to col...
14616275 - Quantification of contact surface pressure exerted during external cephalic version.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Clinical trials and meta-analysis     Volume:  29     ISSN:  0927-5401     ISO Abbreviation:  Clin Trials Metaanal     Publication Date:  1994 Apr 
Date Detail:
Created Date:  1995-06-01     Completed Date:  1995-06-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9212070     Medline TA:  Clin Trials Metaanal     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  49-56     Citation Subset:  T    
Affiliation:
Service de Cardiologie, Hôpital Broussais, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina Pectoris / prevention & control
Aorta / drug effects
Blood Pressure / drug effects
Cardiac Output / drug effects
Coronary Disease / drug therapy*,  physiopathology
Double-Blind Method
Exercise Tolerance / drug effects
Female
Heart Rate / drug effects
Hemodynamics / drug effects*
Humans
Injections, Intravenous
Male
Middle Aged
Placebos
Pulmonary Wedge Pressure / drug effects
Trimetazidine / administration & dosage,  therapeutic use*
Vascular Resistance / drug effects
Ventricular Function, Left / drug effects
Ventricular Pressure / drug effects
Chemical
Reg. No./Substance:
0/Placebos; 5011-34-7/Trimetazidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo a...
Next Document:  From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of n...